Autoantibody levels as biomarkers of disease activity in the management of myasthenia gravis

被引：2
|
作者：
Li, Hai-Feng [1 ,4 ]
Gao, Feng [2 ]
Chen, Xiang-Jun [3 ]
机构：
[1] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[2] Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Dept Neuroimmunol, Zhengzhou, Peoples R China
[3] Fudan Univ, Huashan Hosp, Inst Neurol, Dept Neurol, Shanghai, Peoples R China
[4] Capital Med Univ, Xuanwu Hosp, Dept Neurol, 45 Changchun St, Beijing 100053, Peoples R China
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷 / 04期
关键词：
D O I：
10.1111/ene.15687
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1160 / 1161
页数：2
相关论文
共 50 条
  • [1] Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal
    Meisel, Andreas
    Baggi, Fulvio
    Behin, Anthony
    Evoli, Amelia
    Kostera-Pruszczyk, Anna
    Mantegazza, Renato
    Morales, Raul Juntas
    Punga, Anna Rostedt
    Sacconi, Sabrina
    Schroeter, Michael
    Verschuuren, Jan
    Crathorne, Louise
    Holmes, Kris
    Leite, Maria-Isabel
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (01) : 266 - 282
  • [2] Myasthenia gravis complement activity is independent of autoantibody titer and disease severity
    Fichtner, Miriam L.
    Hoarty, Michelle D.
    Vadysirisack, Douangsone D.
    Munro-Sheldon, Bailey
    Nowak, Richard J.
    O'Connor, Kevin C.
    PLOS ONE, 2022, 17 (03):
  • [3] Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
    Lazaridis, Konstantinos
    Tzartos, Socrates J.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [4] Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal "
    Meisel, Andreas
    Baggi, Fulvio
    Behin, Anthony
    Evoli, Amelia
    Kostera-Pruszczyk, Anna
    Mantegazza, Renato
    Juntas Morales, Raul
    Punga, Anna Rostedt
    Sacconi, Sabrina
    Schroeter, Michael
    Verschuuren, Jan
    Crathorne, Louise
    Holmes, Kris
    Leite, Maria-Isabel
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (04) : 1162 - 1164
  • [5] Autoantibody to dihydropyridine receptor in myasthenia gravis
    Maruta, Takahiro
    Yoshikawa, Hiroaki
    Fukasawa, Shuichi
    Umeshita, Sho
    Inaoka, Yoshihiro
    Edahiro, Shigeki
    Kado, Hirotsugu
    Motozaki, Yuko
    Iwasa, Kazuo
    Yamada, Masahito
    JOURNAL OF NEUROIMMUNOLOGY, 2009, 208 (1-2) : 125 - 129
  • [6] AUTOANTIBODY REPERTOIRE IN MYASTHENIA-GRAVIS
    LEFVERT, AK
    HOLM, G
    JOURNAL OF NEUROIMMUNOLOGY, 1987, 16 (01) : 103 - 103
  • [7] Classification of myasthenia gravis based on autoantibody status
    Suzuki, Shigeaki
    Utsugisawa, Kimiaki
    Nagane, Yuriko
    Satoh, Takashi
    Terayama, Yasuo
    Suzuki, Norihiro
    Kuwana, Masataka
    ARCHIVES OF NEUROLOGY, 2007, 64 (08) : 1121 - 1124
  • [8] Myasthenia gravis — autoantibody characteristics and their implications for therapy
    Nils Erik Gilhus
    Geir Olve Skeie
    Fredrik Romi
    Konstantinos Lazaridis
    Paraskevi Zisimopoulou
    Socrates Tzartos
    Nature Reviews Neurology, 2016, 12 : 259 - 268
  • [9] Myasthenia gravis - autoantibody characteristics and their implications for therapy
    Gilhus, Nils Erik
    Skeie, Geir Olve
    Romi, Fredrik
    Lazaridis, Konstantinos
    Zisimopoulou, Paraskevi
    Tzartos, Socrates
    NATURE REVIEWS NEUROLOGY, 2016, 12 (05) : 259 - U91
  • [10] New autoantibody against transglutaminase in myasthenia gravis
    Choi, YC
    Kim, SY
    NEUROMUSCULAR DISORDERS, 2002, 12 (7-8) : 734 - 734
12345